重新定义遗传性卵巢癌的风险,生物标志物和精确疗法:一篇评论
Ambika Nand Jha1, Varsha Ratan Gaikwad2, Ashok Kumar Gupta1
1School of Pharmacy, Sharda University, Greater Noida, Uttar Pradesh 201306, India.
ACS omega
|September 2, 2025
概括
了解遗传性卵巢癌 (HOC) 涉及遗传易感性,特别是BRCA1/BRCA2突变. 风险评估,预防和PARP抑制剂的进展为这种致命的妇科恶性瘤提供了更好的结果.
科学领域:
- 癌症学
- 遗传学
- 流行病学
背景情况:
- 遗传性卵巢癌 (HOC) 是一个严重的健康负担,
- 在BRCA1和BRCA2基因中的致病性生殖基因突变是HOC的主要驱动因素.
- 这些突变会损害DNA修复,导致基因组不稳定性和癌症风险增加.
研究的目的:
- 审查遗传性卵巢癌的发展情况.
- 专注于药物流行病学,风险评估,化疗预防和向治疗.
- 完善临床决策和推进HOC的精密医学.
主要方法:
- 关于遗传性卵巢癌的文献综述
- 风险评估模型的分析 (BRCAPRO,BOADICEA).
- 评估预防策略 (RRSO,化疗预防) 和向治疗 (PARP抑制剂).
主要成果:
- 基因查有助于早期发现和预防HOC.
- 降低风险的卵巢切除术和化疗预防减少了OC的发生率.
- 在PARP抑制剂显著改善了HOC的无进展生存率.
结论:
- 精准医疗方法正在彻底改变HOC的管理.
- 针对性治疗,如PARP抑制剂对于同类重组缺陷瘤至关重要.
- 持续的研究旨在改善遗传性卵巢癌患者的治疗结果.
更多相关视频
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
13.3K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
